Artemis Medicare Services Gears Up for Q3 Reveal on 2nd February; Check Key Expectations Here

Artemis Medicare Services’s Q3 results FY26 are scheduled to be announced on 2nd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Artemis Medicare Services Q3 Results 2026 Preview

• Artemis Medicare Services’ revenue is expected to be in the range of ₹232.39 crore, a 3.74% YoY decrease. 
• Profit After Tax, or PAT, is projected to fall by 7.16% YoY. 
• Net profit is ₹108.60 crore, down 7.16% YoY 
• EBITDA to rise 15.54%

Artemis Medicare Services Share Performance 

• Over the past six months, Artemis Medicare Services’ share price has risen by 2.82% to ₹251.82.
• Moreover, over the past year, the stock has decreased by 20.07%.
• Despite this weak short-term performance, Artemis Medicare Services’ stock has delivered a financially sound 1,040.49% return over the past 5 years.
• As of 1st February 2026, the stock traded at ₹250.73 per share.

Key Factors to Watch for Artemis Medicare Services Q3 Results FY26 

• Revenue growth & ARPOB trends: Look for top-line growth and whether average revenue per occupied bed (ARPOB) improves, reflecting demand and pricing power.
• Occupancy & utilisation: Changes in bed capacity utilisation signal how efficiently existing capacity is being used.
• Profitability & margins: Watch EBITDA and PAT margins, especially if operational efficiency gains seen in recent quarters continue.
• International patient inflow: The share and growth of revenue from international patients can boost ARPOB and margins.
• Expansion/operational updates: Management commentary on the ramp-up of new facilities (e.g., the third tower/Raipur hospital) and the associated cost impacts will influence the forward outlook.

Final Thoughts

Artemis Medicare Services will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 3.74% YoY revenue growth, a 7.16 rise in PAT, and a 16.33% fall in EBITDA. Artemis Medicare Services focuses on delivering tertiary and quaternary healthcare services through multi-specialty hospitals, with strength in oncology, cardiology, neurology, and advanced surgeries.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here